Bay Area biotech unicorn suffers 5th worst Wall Street debut of year
October 11, 2019 at 17:49 PM EDT
The San Francisco company's market cap dropped by about $700 million in its first day of trading.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|